Artivion | CRY - Net Income


Artivion reported $2.42M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Accuray USD 2.54M 6.49M Dec/2024
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 8.96M 8.85M Jun/2026
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Inogen USD -5.96M 373K Sep/2024
Integra LifeSciences USD 4.48M 9.1M Jun/2026
J&J USD 5.53B 299M Jun/2026
Mesa Laboratories USD -1.68M 5.1M Dec/2024
Orthofix International USD -2.22M 20.57M Dec/2025
Pfizer USD -248M 2.94B Jun/2026
ResMed USD 383.43M 15.3M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026
Trinity Biotech USD -17.48M 12.34M Dec/2025